CVS HEALTH CORPORATION SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense
CVS HEALTH CORPORATION (CVS) reported SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense of $177.00 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-14.
Discontinued › Notes › Valuation and Qualifying Accounts
us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense · last filed 2018-02-14
- CVS HEALTH CORPORATION sec schedule, 12-09, valuation allowances and reserves, additions, charge to cost and expense for fiscal 2017 was $177.00M, a 19.91% decline from fiscal 2016.
- CVS HEALTH CORPORATION sec schedule, 12-09, valuation allowances and reserves, additions, charge to cost and expense for fiscal 2016 was $221.00M, a 2.31% increase from fiscal 2015.
- CVS HEALTH CORPORATION sec schedule, 12-09, valuation allowances and reserves, additions, charge to cost and expense for fiscal 2015 was $216.00M, a 16.76% increase from fiscal 2014.
- CVS HEALTH CORPORATION sec schedule, 12-09, valuation allowances and reserves, additions, charge to cost and expense for fiscal 2014 was $185.00M, a 5.13% decline from fiscal 2013.
| Period end | SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense 12 month |
|---|---|
| 2017-12-31 | $177.00M 10-K · filed 2018-02-14 |
| 2016-12-31 | $221.00M 10-K · filed 2018-02-14 |
| 2015-12-31 | $216.00M 10-K · filed 2018-02-14 |
| 2014-12-31 | $185.00M 10-K · filed 2017-02-09 |
| 2013-12-31 | $195.00M 10-K · filed 2016-02-09 |
| 2012-12-31 | $149.00M 10-K · filed 2015-02-10 |
| 2011-12-31 | $129.00M 10-K · filed 2014-02-11 |
| 2010-12-31 | $73.00M 10-K · filed 2013-02-15 |
| 2009-12-31 | $135.00M 10-K · filed 2012-02-17 |
| 2008-12-31 | $121.00M 10-K · filed 2011-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PETMED EXPRESS INC (PETS) | United States | $0.034B | -1.41 |